Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122K Buy
12,413
+2
+0% +$19 0.06% 128
2026
Q1
$124K Hold
12,411
0.07% 117
2025
Q4
$122K Hold
12,411
0.07% 119
2025
Q3
$114K Sell
12,411
-455
-4% -$4.38K 0.06% 121
2025
Q2
$132K Buy
12,866
+7
+0.1% +$74 0.08% 112
2025
Q1
$129K Hold
12,859
0.09% 107
2024
Q4
$117K Hold
12,859
0.07% 102
2024
Q3
$129K Buy
12,859
+3
+0% +$29 0.09% 103
2024
Q2
$113K Buy
12,856
+259
+2% +$2.17K 0.07% 100
2024
Q1
$103K Hold
12,597
0.07% 98
2023
Q4
$107K Buy
12,597
+3
+0% +$25 0.08% 96
2023
Q3
$105K Hold
12,594
0.09% 96
2023
Q2
$102K Hold
12,594
0.07% 108
2023
Q1
$103K Buy
12,594
+4
+0% +$32 0.08% 104
2022
Q4
$98.8K Hold
12,590
0.08% 95
2022
Q3
$75K Buy
+12,590
New +$81.5K 0.07% 92

Other funds holding HLN

Ballew Advisors's HLN Position: Q2 2026 in Review

Ballew Advisors increased its Haleon (HLN) stake by 0.02% in Q2 2026, buying an estimated $19 and bringing the position to 12,413 shares worth $122K. The position accounts for 0.06% of the portfolio, ranked #128.

Ballew Advisors first reported a position in HLN in Q3 2022 and has held it in 16 quarters since. The position peaked at $132K in Q2 2025. 639 funds tracked by Wall St. Rank hold HLN as of Q2 2026.

  • Ballew Advisors held 12,413 shares of Haleon worth $122K as of Q2 2026.
  • Ballew Advisors bought 2 Haleon shares in Q2 2026, an estimated $19.
  • Haleon made up 0.06% of Ballew Advisors's portfolio in Q2 2026, its #128 holding.
  • Ballew Advisors first reported a position in Haleon in Q3 2022 and has held it in 16 quarters since.
  • Ballew Advisors's Haleon position peaked at $132K in Q2 2025.
  • 639 funds tracked by Wall St. Rank held Haleon as of Q2 2026.

Based on Ballew Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.